// App-Quantinova.ai

236 : Timing of high-dose rate brachytherapy with external beam radiotherapy in intermediate and high-risk localized prostate cancer (THEPCA) patients and its effects on toxicity and quality of life: Results of a randomized feasibility trial.

Researchers

Presenter

  • Imtiaz Ahmed

Principal Investigators

  • Sharon Shibu Thomas

  • Alexander Cain

  • Jufen Zhang

  • Sreekanth Palvai

  • Dabden Dawam

  • Rakesh Kizhakke Veetil

  • Lavinia Romero

  • Karen Hayden

  • Mahbuba Choudhury

Medical Centers

  • Southend NHS Trust, Southend, United Kingdom

  • Southend University Hospital NHS Foundation Trust, Southend, United Kingdom

  • Southend University Hospital, Southend on Sea, United Kingdom

  • Anglia Ruskin University, Cambridge, United Kingdom

  • Southend University Hospital NHS Trut, Westcliff on Sea, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • GATA Binding Protein 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • NCT02618161

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved